referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ says
**Introduction**
Private‑equity heavyweight Warburg Pincus is reportedly in the final stages of a $7 billion takeover of PANTHERx Rare, a specialty‑pharmacy firm that focuses on high‑cost, low‑volume medications. The Wall Street Journal first broke the story, noting that the transaction 顶: 75455踩: 8472
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ says
人参与 | 时间：2026-09-24 01:50:40
相关文章
- Major Healthcare Shakeup: Community Health Systems Divests Four Arkansas Hospitals to Freeman
- Discover the Truth: Is the Rare Totoaba Actually a White Sea Bass?
- RXT Investors Set to Lead High‑Stakes Rackspace Fraud Lawsuit
- Unleash lightning-fast performance with 11 tiny macOS tweaks
- The Alarming Consequences of Being Indifferent: A Threat to Humanity's Future
- Jury Convicts Former Gang Leader for Tupac Shakur's Murder, Shocking Verdict
- Tragic Himalayan Disaster Leaves 80 Americans Missing as 903 Die
- Lance Leipold Reveals Emotional Reason Behind Naming Isaiah Marshall Kansas' Starting QB
- Revolutionary AI Breakthrough: PerkyPet Appoints Visionary Jamal Jackson as Global AI Leader
- Kenyans Donate Over KSh1 Million in Heartfelt Tribute to Valery Odundo’s Mother
评论专区